Skip to Main Content

Paper Details

Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Oncologist
13
2022
Author NameAffiliation
Marcia S BroseSidney Kimmel Cancer Center of Jefferson University Health
Alan L HoMemorial Sloan Kettering Cancer Center
Alan L HoWeill Cornell Medical College
Alexander DrilonMemorial Sloan Kettering Cancer Center
Alexander DrilonWeill Cornell Medical College
  • 1 - 5

Datasets

Release 1.2